Project Details
| Acronym | LATA-CS102 |
|---|---|
| Status | Active |
| Effective start/end date | 25/09/20 → 31/05/25 |
An open label, comparative, sequential-dose, multi-centre study involving intracameral administration of a PA5108 Latanoprost FA SR Ocular Implant into the eye of patients with mild-moderate glaucoma
- Graham, Stuart L. (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Rai, Meenal (Clinical Trial Unit Staff)
Project: Research